L M Mongioi
Overview
Explore the profile of L M Mongioi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
La Vignera S, Condorelli R, Cannarella R, Cimino L, Mongioi L, Duca Y, et al.
Aging Male
. 2020 Jun;
23(5):1440-1441.
PMID: 32571110
No abstract available.
2.
Cannarella R, Calogero A, Condorelli R, Giacone F, Mongioi L, La Vignera S
Eur Rev Med Pharmacol Sci
. 2019 Apr;
23(7):3112-3120.
PMID: 31002161
Objective: Male infertility is a wide spread disease among couple of childbearing age. Spermatozoa are highly susceptible to oxidative stress. Reactive oxygen species (ROS) are capable of damaging the sperm...
3.
Mongioi L, Condorelli R, La Vignera S, Calogero A
Endocr Connect
. 2017 Dec;
7(1):211-219.
PMID: 29233815
Objective: Adrenal insufficiency (AI) is a chronic condition associated with increased mortality and morbidity. The treatment of AI in the last years has been object of important changes due to...
4.
Condorelli R, Calogero A, DI Mauro M, Mongioi L, Cannarella R, Rosta G, et al.
J Endocrinol Invest
. 2017 Sep;
41(4):383-388.
PMID: 28942551
Background: Insulin resistance is a common feature among women with polycystic ovary syndrome (PCOS), especially in those patients with hyperandrogenism and chronic anovulation. PCOS women are at risk for developing...
5.
Condorelli R, La Vignera S, Mongioi L, Vitale S, Lagana A, Cimino L, et al.
Eur Rev Med Pharmacol Sci
. 2017 Jul;
21(2 Suppl):30-35.
PMID: 28724176
Myo-inositol (MYO) usually represents a therapeutic option for female infertility associated with insulin resistance. Recently, several evidences are accumulating about the potential use of MYO for the treatment of male...
6.
Cannarella R, Condorelli R, Mongioi L, La Vignera S, Calogero A
J Endocrinol Invest
. 2017 Jul;
41(1):49-57.
PMID: 28711970
The occurrence of a genetic background in the etiology of polycystic ovarian syndrome (PCOS) represents the rational basis to postulate the existence of a male PCOS equivalent. Hormonal and metabolic...
7.
Tamburino L, La Vignera S, Tomaselli V, Condorelli R, Cannarella R, Mongioi L, et al.
J Assist Reprod Genet
. 2017 Jun;
34(10):1289-1294.
PMID: 28624859
Purpose: The functional role of the FSHR promoter -29G/A polymorphism (rs1394205) in men is not clear. Some studies failed to find a relationship between the FSHR -29G/A and follicle-stimulating hormone...
8.
Tamburino L, La Vignera S, Tomaselli V, Condorelli R, Mongioi L, Calogero A
J Assist Reprod Genet
. 2017 Mar;
34(5):671-676.
PMID: 28281143
Purpose: The FSHB gene -211G/T polymorphism has been reported to modulate gene expression and to cause inter-individual differences in FSH serum levels in men. This study was undertaken to assess...
9.
Calogero A, Giagulli V, Mongioi L, Triggiani V, Radicioni A, Jannini E, et al.
J Endocrinol Invest
. 2017 Mar;
40(7):705-712.
PMID: 28258556
Klinefelter syndrome (KS) is one of the most common genetic causes of male infertility. This condition is associated with much comorbidity and with a lower life expectancy. The aim of...
10.
La Vignera S, Condorelli R, Mongioi L, Vitale S, Russo G, Lagana A, et al.
Andrologia
. 2016 Nov;
49(8).
PMID: 27882582
Recently, it has been reported that treatment with testosterone (T) could have favourable effects on prostate inflammation; however, the data appear inconsistent. The main evidences concern experimental studies, and there...